The future of neuroscience: Karl Deisseroth sheds light on the inner workings of the brain

Episode Summary

Executive Summary: Russ Altman interviews Carl Deisseroth about the evolution of neuroscience from a technology-poor field to one increasingly enabled by tools like optogenetics. Deisseroth argues that technology development and basic discovery should be unified, explains how light-based control of neurons became viable, and describes how these methods are now informing both neuroscience causality and psychiatric care—without necessarily requiring direct human brain gene delivery.

Main Topics: Technology as a core part of neuroscience (Priority: 5/5): Deisseroth argues that neuroscience progress depends on building new tools, not just doing more biology. He frames technology development and discovery as inseparable, especially when studying the brain’s complexity and the gap between psychiatry and cellular mechanisms. The origin and logic of optogenetics (Priority: 5/5): He explains how optogenetics emerged from testing multiple approaches to control cells and why light-based control won: it offered cellular precision in complex behaving animals. The technology uses microbial opsins as light-sensitive membrane proteins. From basic discovery to human relevance (Priority: 5/5): Optogenetics is presented not only as a research tool but as a path toward therapy. Deisseroth emphasizes that understanding the causal cells and circuits behind symptoms can reveal drug targets and therapeutic strategies, even without putting genes into patients. Clinical psychiatry informing research (Priority: 4/5): As a practicing psychiatrist, Deisseroth says direct patient care shapes his lab’s priorities. Acute inpatient work and long-term outpatient relationships give him insight into what symptoms actually feel like and what matters clinically, improving experimental design. The Brain Initiative and cell-type resolution (Priority: 4/5): He describes the NIH Brain Initiative as a push to build a parts list of the brain, identifying hundreds or thousands of cell types and then using tools like optogenetics to test what each contributes to behavior and disease. Causality, correlation, and network-level brain dynamics (Priority: 5/5): Deisseroth stresses that the brain is so interconnected that correlation is everywhere; therefore, causal interventions are essential to identify what truly drives behavior or symptoms. He notes that large-scale recordings can show widespread correlations even for simple actions. Writing 'Projections' and communicating psychiatry (Priority: 3/5): He explains that his book was meant to convey the inner experience of psychiatric illness and the scientific progress behind it, using literary style tailored to each disorder while staying rigorously grounded in science.

Key Arguments: Neuroscience cannot advance far enough on biology alone; it requires deliberate technology development as a central scientific activity. Optogenetics succeeded because the team tried many approaches and followed the ones that produced a real signal from nature, rather than assuming a solution in advance. The practical value of optogenetics lies in its precision: it can turn specific cells on or off in behaving mammals with light. Microbial opsins were a high-risk choice because they were evolutionarily distant from mammals and potentially toxic in neuronal membranes, yet they proved workable. Direct optogenetics in humans is already possible in limited contexts, demonstrated in the retina for a patient with retinitis pigmentosa. Therapeutic impact does not require direct human gene delivery; basic causal understanding can identify drug targets and circuit interventions. Clinical psychiatry offers indispensable grounding because symptoms are lived experiences, not just checklist items, and that should shape experiments. Because the brain is highly interconnected, simple correlations are insufficient; causal manipulation is necessary to determine what matters. The Brain Initiative’s early focus on cell types was a necessary foundation for bringing causal tools to bear on brain function. Theory is needed to manage the combinatorial explosion created by the ability to record and manipulate many brain regions and cell types simultaneously.

Data Points: Brain Initiative technology phase: first 5 years - Altman references the NIH roadmap’s initial emphasis on developing new neuroscience technologies before focusing on major scientific problems. Direct optogenetic human result: 2 years ago - Deisseroth cites a collaborator in Switzerland enabling a blind person with retinitis pigmentosa to identify objects on a table. Lab allocation to technology development: about a quarter to half of time - He says even researchers who see themselves as pure biologists in his lab spend substantial time developing technology. Optogenetic scale now achievable: hundreds or thousands of individually specified cells - He describes current capability to control large numbers of precisely identified cells with tailored stimulation patterns. Large-scale brain recording study: tens of thousands of cells - He mentions a 2019 experiment recording electrically across the brain while a thirsty mouse drank water. Correlation finding: more than half - In that recording study, more than half of all neurons across the brain correlated with the simple action of drinking water. Clinical psychiatry frequency: about one week a year - Deisseroth says he does acute inpatient/emergency psychiatry for roughly one week annually. Book structure: each chapter deals with a different psychiatric disorder - He explains that 'Projections' uses distinct stylistic choices for different conditions, such as mania and schizophrenia.

Pivotal Quotes: "it was all about even if you're basic science, even if you were a pure biologist, you had to develop technologies as a primary goal, honestly." — Carl Deisseroth: He explains his philosophy that technology development is not secondary to neuroscience but central to it. "what optogenetics is, it's a way of controlling specific cells with light." — Carl Deisseroth: He gives a concise definition of the core technology discussed in the episode. "The brain is so fast and so interconnected that everything ends up being correlated more or less." — Carl Deisseroth: He explains why correlation alone is insufficient and why causal interventions are needed.

Implications: The episode suggests neuroscience’s future depends on precise tools, causal experiments, and clinician-scientist feedback loops. For mental health, the big payoff may come less from direct brain editing and more from discovering circuits and targets that can guide safer therapies.